Search

everythinglearnresearchcommunity

for

Search:↓

A woman with lupus had rare severe symptoms but improved with treatment.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Women with PCOS often have more hair growth, skin darkening, and acne, which are linked to hormonal and metabolic issues.

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

New hair and scalp disease diagnosis methods are important for correct treatment.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Genetic testing can help diagnose skin conditions but needs more research for full effectiveness.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

People with alopecia areata may have a higher risk of blood clots.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Obese women with PCOS are more likely to have fatty liver disease.

The document concludes that more research is needed to fully understand the causes of PCOS.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Apoptosis may contribute to hair loss in androgenetic alopecia.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

Certain skin symptoms can help detect and manage systemic lupus.